CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.00K shares, a 99.37% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 158.00K shares, a 18.97% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 195.00K shares, a 10.96% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 219.00K shares, a 49.19% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-27 | 1.00K shares 10-K · filed 2026-02-18 | |
| 2024-12-28 | 158.00K shares 10-K · filed 2025-02-19 | |
| 2023-12-30 | 195.00K shares 10-K · filed 2024-02-14 | |
| 2022-12-31 | 219.00K shares 10-K · filed 2023-02-22 | |
| 2021-12-25 | 431.00K shares 10-K · filed 2022-02-16 | |
| 2020-12-26 | 533.00K shares 10-K · filed 2021-02-17 | |
| 2019-12-28 | 442.00K shares 10-K · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |